These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17229074

  • 1. Epstein-Barr virus: evasive maneuvers in the development of PTLD.
    Snow AL, Martinez OM.
    Am J Transplant; 2007 Feb; 7(2):271-7. PubMed ID: 17229074
    [Abstract] [Full Text] [Related]

  • 2. Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival.
    Sang AX, McPherson MC, Ivison GT, Qu X, Rigdon J, Esquivel CO, Krams SM, Martinez OM.
    Am J Transplant; 2019 May; 19(5):1305-1314. PubMed ID: 30549430
    [Abstract] [Full Text] [Related]

  • 3. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM, Krams SM.
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus, rapamycin, and host immune responses.
    Krams SM, Martinez OM.
    Curr Opin Organ Transplant; 2008 Dec; 13(6):563-8. PubMed ID: 19060543
    [Abstract] [Full Text] [Related]

  • 5. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 6. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder.
    Maloney EM, Busque VA, Hui ST, Toh J, Fernandez-Vina M, Krams SM, Esquivel CO, Martinez OM.
    JCI Insight; 2020 Mar 26; 5(6):. PubMed ID: 32213705
    [Abstract] [Full Text] [Related]

  • 7. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR, Nalesnik MA, Swerdlow SH.
    Am J Surg Pathol; 2006 Dec 26; 30(12):1604-12. PubMed ID: 17122518
    [Abstract] [Full Text] [Related]

  • 8. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
    Tanner JE, Alfieri C.
    Transpl Infect Dis; 2001 Jun 26; 3(2):60-9. PubMed ID: 11395971
    [Abstract] [Full Text] [Related]

  • 9. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Jun 26; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 10. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
    Green M, Reyes J, Webber S, Rowe D.
    Transpl Infect Dis; 2001 Jun 26; 3(2):97-103. PubMed ID: 11395975
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A, Spieker T, Mottok A, Baur AS, Küppers R, Hansmann ML.
    Eur J Immunol; 2003 Jun 26; 33(6):1593-602. PubMed ID: 12778477
    [Abstract] [Full Text] [Related]

  • 12. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS, Lemas MV, Ambinder RF.
    Transpl Infect Dis; 1999 Sep 26; 1(3):204-12. PubMed ID: 11428990
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas.
    Finberg RW.
    Curr Opin Oncol; 2001 Sep 26; 13(5):349-53. PubMed ID: 11555711
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
    Swinnen LJ.
    J Natl Cancer Inst Monogr; 2001 Sep 26; (28):38-43. PubMed ID: 11158205
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
    Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner PH, Swinnen JL, Woodle ES, Bromberg JS.
    Transplantation; 1999 Nov 27; 68(10):1517-25. PubMed ID: 10589949
    [Abstract] [Full Text] [Related]

  • 16. The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.
    AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S.
    Am J Transplant; 2017 Mar 27; 17(3):770-781. PubMed ID: 27545492
    [Abstract] [Full Text] [Related]

  • 17. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.
    J Pediatr Gastroenterol Nutr; 2001 Oct 27; 33(4):445-9. PubMed ID: 11698761
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
    Zaffiri L, Frankel C, Bush EJ, Neely ML, Pavlisko EN, Mokrova IL, Luftig MA, Palmer SM.
    J Med Virol; 2021 Aug 27; 93(8):5040-5047. PubMed ID: 33704812
    [Abstract] [Full Text] [Related]

  • 20. Biomarkers for PTLD diagnosis and therapies.
    Martinez OM.
    Pediatr Nephrol; 2020 Jul 27; 35(7):1173-1181. PubMed ID: 31240394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.